Antipodes Partners »

Regeneron Pharmaceuticals shares owned by Antipodes Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Antipodes Partners from 13F filings

Historical chart of Antipodes Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Antipodes Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Antipodes Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $75k 97 771.93